Clinical Trials | August 06, 2025
AbbVie announces positive Phase 3 results for Upadacitinib in Alopecia Areata
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
Strengthening focus in Alzheimer's disease and neuroscience pipeline
Akums Drugs will undertake this development and commercialization in India
Subscribe To Our Newsletter & Stay Updated
